r personal use only

(ASX: ANP)

AGM Presentation

December 2021

only

Forward Looking Statements

This presentation contains forward‐looking statements regarding the Company's business & the therapeutic & commercial

usepotential of its technologies & products in development. Any statement describing the Company's goals, expectations, intentions or beliefs is a forward‐looking statement & should be considered an at‐risk statement. Such statements are subject to certain risks & uncertainties, particularly those risks or uncertainties inherent in the process of developing technology & in the process of discovering, developing & commercializing drugs that can be proven to be safe & effective for use as human therapeutics, & in the endeavor of building a business around such products & services. Actual results could differ materially

from those discussed in this presentation. Factors that could cause or contribute to such differences include, but are not limited personalr

to, those discussed in the Antisense Therapeutics Limited Annual Report for the year ended 30 June 2021, which is available from the Company or at www.antisense.com.au.

2

r personal use only

Charmaine Gittleson MD

Board Chair

3

r personal use only

ANP Corporate Video

4

r personal use only

Key Strategic Factors for ANP Success

Expand on

value

proposition

Refine ANP

Deliver on

Leverage

business

ATL1102

research

model

promise

for future

Leverage expertise

5

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Antisense Therapeutics Limited published this content on 14 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 December 2021 23:28:05 UTC.